Oct 7, 2025
Combivir vs. Other HIV Regimens: Comparing Popular Alternatives
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.